Cargando…
Effectiveness and Safety of Ticagrelor Implementation in Patients with Acute Coronary Syndrome undergoing Percutaneous Coronary Intervention: A Cohort Study in Western Denmark
BACKGROUND: Ticagrelor was introduced in Denmark in 2011 after randomised data showed its superiority over clopidogrel for patients with acute coronary syndrome (ACS). We assessed the effectiveness and safety of ticagrelor implementation in ACS patients undergoing percutaneous coronary intervention...
Autores principales: | Thrane, Pernille Gro, Olesen, Kevin Kris Warnakula, Würtz, Morten, Gyldenkerne, Christine, Madsen, Morten, Jensen, Lisette Okkels, Raungaard, Bent, Sørensen, Henrik Toft, Thim, Troels, Kristensen, Steen Dalby, Maeng, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802857/ https://www.ncbi.nlm.nih.gov/pubmed/35146473 http://dx.doi.org/10.1016/j.lanepe.2021.100301 |
Ejemplares similares
-
Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study
por: Olesen, Kevin Kris Warnakula, et al.
Publicado: (2021) -
Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus
por: Gyldenkerne, Christine, et al.
Publicado: (2019) -
Extent of coronary artery disease is associated with myocardial infarction and mortality in patients with diabetes mellitus [Response to Letter]
por: Olesen, Kevin Kris Warnakula, et al.
Publicado: (2019) -
Diabetes is not a risk factor for myocardial infarction in patients without coronary artery disease: A study from the Western Denmark Heart Registry
por: Gyldenkerne, Christine, et al.
Publicado: (2020) -
Cardiovascular risk in patients with and without diabetes presenting with chronic coronary syndrome in 2004–2016
por: Jensen, Esben Skov, et al.
Publicado: (2021)